FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 87 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |
| Parkwood LLC | 24,081 | $675,000 | 0.12% |
| Marble Harbor Investment Counsel, LLC | 23,864 | $669,000 | 0.09% |
| Lone Pine Capital | 800,000 | $22,416,000 | 0.08% |
| Virtus ETF Advisers LLC | 6,276 | $176,000 | 0.07% |
| Windsor Creek Advisors, LLC | 8,000 | $224,000 | 0.06% |
| Maven Securities LTD | 38,200 | $976,000 | 0.04% |
| Chicago Partners Investment Group LLC | 14,925 | $410,000 | 0.03% |
| Candriam S.C.A. | 123,004 | $4,124,000 | 0.03% |
| Alyeska Investment Group, L.P. | 87,215 | $2,444,000 | 0.03% |
| Marshall Wace North America L.P. | 184,875 | $5,180,000 | 0.02% |
External links
This page lists FORMA THERAPEUTICS HLDGS INC's shareholders in Q1 2021. To view FORMA THERAPEUTICS HLDGS INC's shareholder history, click here.